Related Experiment Video
Updated: Jan 21, 2026

Extraction and Analysis of Taiwanese Green Propolis
Published on: January 7, 2019
Newborn screening: Taiwanese experience
Yin-Hsiu Chien1,2, Wuh-Liang Hwu1,2, Ni-Chung Lee1,2
1Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan.
Insights
Newborn screening (NBS) for Pompe disease in Taiwan has evolved, identifying patients early. Challenges remain in managing diagnosed infants without symptoms and improving current therapies.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Pompe disease, a rare genetic disorder, requires early diagnosis for effective treatment.
- Newborn screening (NBS) is crucial for identifying Pompe disease in asymptomatic infants.
- Taiwan's population presents unique challenges due to a prevalent pseudodeficiency variant.
Purpose of the Study:
- To describe the evolution of NBS methods for Pompe disease in Taiwan.
- To review and update the outcomes of NBS-identified Pompe disease patients.
- To discuss limitations in current Pompe disease therapy and challenges in managing diagnosed infants.
Main Methods:
- Review of historical and current NBS methodologies for Pompe disease in Taiwan.
- Analysis of clinical outcomes for infants identified through NBS.
- Literature review on current therapeutic limitations and management strategies.
Main Results:
- The evolution of NBS in Taiwan has enabled earlier diagnosis of Pompe disease.
- Outcomes for NBS-identified patients have been updated, highlighting treatment efficacy and limitations.
- Significant challenges exist in managing infants diagnosed via NBS but showing no immediate clinical manifestations.
Conclusions:
- Continued refinement of NBS protocols is necessary for optimal Pompe disease detection.
- Current therapies for Pompe disease have limitations, necessitating further research.
- Development of predictive biomarkers and improved treatment strategies are essential for managing diagnosed infants.
Abstract:
Newborn screening (NBS) aims to diagnose patients with Pompe disease earlier so that timely treatment can be applied. We describe the evolution of the screening methods in Taiwan with a population in which a pseudodeficiency variant is prevalent. We review and update the outcome of NBS-identified patients and discuss the limitations of the current therapy. We also address the challenges associated with caring for the babies with diagnosed acid alpha-glucosidase deficiency but yet without significant clinical manifestations. Further modifications of the current treatment and better predictive biomarkers should be explored.
Related Concept Videos
What is an Experiment?
Thomson's e/m Experiment
A particle with charge q, speed v, and mass m enters an area from the top, where the magnetic and electric fields are perpendicular both to the particle's motion and to one another. The magnetic...
Controls in Experiments
Randomized Experiments
Simple randomization
Simple...
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
The Stanford Prison Experiment

